Tests a faith-based program to encourage cancer and aneurysm screening in Black adults
Tests a faith-based workshop to encourage screening for breast, cervical and bowel cancer and AAA.
Plain-language title generated from the registry record
Registry title: EQUITA - A Feasibility Trial of a Faith-placed Intervention to Increase Screening Uptake in Black Adults
Key facts
- Where
- Glasgow, Leeds, and Sunderland, United KingdomSee the 3 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 25 and 74 years old?
Source: NCT06981182, who can take part
Where in United Kingdom
- University of GlasgowGlasgow, United KingdomNo longer taking part
- Leeds Beckett UniversityLeeds, United KingdomNo longer taking part
- University of SunderlandSunderland, United KingdomNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Sunderland
- Trial code
- NCT06981182
- Record updated
- 20 May 2025
- Original description
The goal of this randomised feasibility trial is to examine feasibility and acceptability of a co-produced and faith-placed intervention to increase uptake of breast, cervical, bowel, and abdominal aortic aneurysm (AAA) screening among Black communities in the North East of England, Leeds and Scotland, United Kingdom (UK).Read full original descriptionShow less
EQUITy in Black Adult Health (EQUITA) - a Randomised Feasibility Trial of a Co-produced and Faith-placed Intervention to Increase Uptake of Breast, Cervical, Bowel, and AAA Screening in the North East of England, Leeds and Scotland
The goal of this randomised feasibility trial is to examine feasibility and acceptability of a co-produced and faith-placed intervention to increase uptake of breast, cervical, bowel, and abdominal aortic aneurysm (AAA) screening among Black communities in the North East of England, Leeds and Scotland, United Kingdom (UK).
Participants will be invited to attend a two-hour workshop at each of the three study sites and will be randomly assigned to either the intervention group or the control group.
This 24-month feasibility study will inform the development of a full-scale randomised-controlled trial co-produced for Black people that uses culturally appropriate messages that support screening for early diagnosis in this underserved group.
Inclusion: Members of participating churches (North East of England, Leeds, Scotland); Self-identify as Black,; Female aged 25-74,; Male aged 50-74,; Not up to date with all screening tests for which they are eligible, e.g., women who are up to date with one form of screening (e.g., breast) will be eligible for recruitment if they are not up to date with others (e.g., cervical or bowel).
Exclusion: Females aged outside the range of 25-74; Males aged outside the range of 50-74; Not a member of participating churches (North East of England, Leeds, Scotland); Individuals who do not self-identify as Black; Do not self-identity as Black; Individuals who are up to date with all screening tests for which they are eligible.